Código QR (código de barras bidimensional)

Treatment‐related neuroendocrine prostate cancer with BRCA2 germline mutation treated with olaparib

Introduction The efficacy of olaparib for treatment‐related neuroendocrine prostate cancer is unknown. Here, we report a case of treatment‐related neuroendocrine prostate cancer with a BRCA2 mutation that was treated with olaparib with 1‐year efficacy. Case presentation A 75‐year‐old man initially d...

ver descrição completa

Na minha lista:
Principais autores: Riko Ikeda, Yoh Matsuoka, Masaharu Inoue, Ayataka Ishikawa, Kiwamu Akagi, Yukio Kageyama
Formato: Artigo
Idioma:Inglês
Publicado em: Wiley 2024-03-01
coleção:IJU Case Reports
Assuntos:
BRCA2
castration‐resistant
neuroendocrine tumor
poly(ADP‐ribose) polymerase inhibitors
prostate cancer
Acesso em linha:https://doi.org/10.1002/iju5.12679
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados